358
Participants
Start Date
December 7, 2016
Primary Completion Date
July 15, 2023
Study Completion Date
June 30, 2026
Chemotherapy
5-FU, Leucovorin, and Oxaliplatin (FOLFOX regimen)
Uijeongbu St. Mary's Hospital, The Catholic University College of Medicine, Uijeongbu-si
Ajou University School of Medicine, Suwon
Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon
Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wŏnju
Soonchunhyang University Cheonan Hospital, Cheonan
Chungnam National University Hospital, Daejeon
Keimyung University Dongsan Medical Center, Daegu
Inje University Busan Paik hospital, Busan
Pusan National University Yangsan Hospital, Yangsan
Wonkwang University Hospital, Iksan
Chonnam National University Hwasun Hospital, Hwasun
Inje University Sanggye Paik Hospital, Seoul
Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul
Seoul St. Mary's Hospital, The Catholic University College of Medicine, Seoul
Collaborators (3)
Korean Society of ColoProctology
UNKNOWN
Pharmbio Korea Inc.
UNKNOWN
Samjin Pharmaceutical Co., Ltd.
INDUSTRY
Boryung Pharmaceutical Co., Ltd
INDUSTRY
JW Pharmaceutical
INDUSTRY
Kyung Hee University Hospital at Gangdong
OTHER